LFCR Lifecore Biomedical, Inc. logo

LFCR Lifecore Biomedical, Inc.

Healthcare
$4.93-1.00%ClosedMarket Cap: $184.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

8.89

P/S

1.37

EV/EBITDA

115.24

DCF Value

$-10.16

FCF Yield

5.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

31.2%

Operating Margin

-0.1%

Net Margin

-25.2%

ROE

-146.7%

ROA

-15.1%

ROIC

-0.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$23.2M$-15.0M$
Q2 null$44.4M$-8.0M$
Q1 null$31.1M$-10.0M$
Q4 null$36.4M$-1.1M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$6.00

Target (Median)

$6.00

Target Range

$6.00 - $6.00

1 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell
Barrington ResearchOutperform
2026-04-29
Barrington ResearchOutperform
2026-03-27

Trading Activity

Insider Trades

View All
Josephs Pauldirector, officer: Chief Executive Officer
SellThu May 21
Salus Thomas D.officer: Chief Legal & Administration
SellThu Apr 16
Salus Thomas D.officer: Chief Legal & Administration
SellMon Mar 02
Lake Ryan Davidofficer: Chief Financial Officer
SellThu Sep 04
Schechter Joshuadirector
SellThu Jul 17

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

Beta

1.08

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

Peers